Document Detail


Staurosporine-induced apoptosis in P388D1 macrophages involves both extrinsic and intrinsic pathways.
MedLine Citation:
PMID:  19524691     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Treatment of P388D1, a macrophage-like cell line, with staurosporine triggered apoptosis through the activation of caspase-9 and caspase-3. Unexpected effects of staurosporine on the induction of apoptosis were the activation of caspase-8, and an increase of the levels of TNF-alpha. The increased TNF-alpha levels led to activation of caspase-8 by an autocrine effect via the TNF receptor expressed by the P388D1 macrophages. In contrast, P388D1 macrophages that either had been exposed to UV light or treated with dexamethasone did not undergo apoptosis.
Authors:
Yuko Nakamura-López; Rosa Elena Sarmiento-Silva; Julio Moran-Andrade; Beatriz Gómez-García
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-06-12
Journal Detail:
Title:  Cell biology international     Volume:  33     ISSN:  1095-8355     ISO Abbreviation:  Cell Biol. Int.     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-08-31     Completed Date:  2009-12-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9307129     Medline TA:  Cell Biol Int     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  1026-31     Citation Subset:  IM    
Affiliation:
Laboratory of Virology, Department of Microbiology and Parasitology, Universidad Nacional Autónoma de México,Ciudad Universitaria, México DF 04510, Mexico.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antineoplastic Agents, Hormonal / pharmacology
Apoptosis*
Caspase 3 / drug effects,  metabolism
Caspase 8 / drug effects,  metabolism
Caspase 9 / drug effects,  metabolism
Cell Line, Tumor
Cell Survival / drug effects,  physiology
DNA Fragmentation / drug effects
Dexamethasone / pharmacology
Macrophages / drug effects*,  radiation effects
Mice
Protein Kinase Inhibitors / pharmacology*
Receptors, Tumor Necrosis Factor, Type I / agonists,  metabolism
Signal Transduction / drug effects,  physiology
Staurosporine / pharmacology*
Tumor Necrosis Factor-alpha / biosynthesis,  drug effects
Ultraviolet Rays / adverse effects
Chemical
Reg. No./Substance:
0/Antineoplastic Agents, Hormonal; 0/Protein Kinase Inhibitors; 0/Receptors, Tumor Necrosis Factor, Type I; 0/Tumor Necrosis Factor-alpha; 50-02-2/Dexamethasone; 62996-74-1/Staurosporine; EC 3.4.22.-/Caspase 3; EC 3.4.22.-/Caspase 8; EC 3.4.22.-/Caspase 9

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Stimulation of the side population fraction of ATDC5 chondroprogenitors by hypoxia.
Next Document:  Role of MEF feeder cells in direct reprogramming of mousetail-tip fibroblasts.